Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Pablo Corral Shares New Insights: Genome Editing and Gene Therapy for Lipid Disorders
Pablo Corral/LinkedIn
Sep 17, 2025, 05:12

Pablo Corral Shares New Insights: Genome Editing and Gene Therapy for Lipid Disorders

Pablo Corral, Past President of Argentine Lipid Society, has shared a post on LinkedIn:

“A must read article

‘Gene therapy and genome editing for lipoprotein disorders‘ provides a comprehensive and timely overview of how advances in genetic medicine—including AAV gene addition, CRISPR editing, and RNA-based strategies—are reshaping the prevention and management of dyslipidaemias and ASCVD.

This open-access article highlights how innovative approaches may overcome limitations of lifelong lipid-lowering therapy, address unmet clinical needs in familial and polygenic disorders, and integrate polygenic risk scores and machine learning to personalize cardiovascular prevention.

An excellent resource for clinicians, researchers, and students interested in the rapidly evolving field of cardiovascular genetics.”

Title: Gene therapy and genome editing for lipoprotein disorders

Authors: Chen Gurevitz, Archna Bajaj, Amit V Khera, Ron Do, Heribert Schunkert, Kiran Musunuru, Robert S Rosenson

Genome Editing

Read the full paper here.

Stay informed with Hemostasis Today.

AAV gene addition Amit V Khera Archna Bajaj Chen Gurevitz CRISPR dyslipidaemia Gene therapy genetic medicine Genome Editing Health Hematology Hemostasis Hemostasis Today Heribert Schunkert Kiran Musunuru Lipid Disorders lipoprotein disorders Pablo Corral Robert S Rosenson Ron Do
NewsFeed